A phase III, open-label, single-dose study to evaluate the safety and immunogenicity of Fluviral trivalent split virion influenza vaccine (2007-2008 season) in adults ranging in age from 18 to 60 years and 61 years and over.

Trial Profile

A phase III, open-label, single-dose study to evaluate the safety and immunogenicity of Fluviral trivalent split virion influenza vaccine (2007-2008 season) in adults ranging in age from 18 to 60 years and 61 years and over.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Nov 2016

At a glance

  • Drugs GSK 1536489A (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 09 Oct 2007 Status change from in progress to completed
    • 18 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top